Cargando…
Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes
BACKGROUND: Prognostic markers for COVID-19 disease outcome are currently lacking. Plasma gelsolin (pGSN) is an actin-binding protein and an innate immune marker involved in disease pathogenesis and viral infections. Here, we demonstrate the utility of pGSN as a prognostic marker for COVID-19 diseas...
Autores principales: | Asare-Werehene, Meshach, McGuinty, Michaeline, Vranjkovic, Agatha, Galipeau, Yannick, Cowan, Juthaporn, Cameron, Bill, Cooper, Curtis L., Langlois, Marc-André, Crawley, Angela M., Tsang, Benjamin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489255/ https://www.ncbi.nlm.nih.gov/pubmed/36148234 http://dx.doi.org/10.3389/fimmu.2022.1011084 |
Ejemplares similares
-
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
por: Onuma, Toshimichi, et al.
Publicado: (2022) -
Cohort profile: Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination
por: Collins, Erin, et al.
Publicado: (2022) -
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2019) -
Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand
por: Chiu, Chen-Tzu, et al.
Publicado: (2020) -
Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin
por: Gerber, Emma, et al.
Publicado: (2023)